☆ 4.7 Letter

Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 77, Issue 22, Pages 2867-2869

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2021.04.011

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Merck (Kenilworth, New Jersey)
  2. Bayer
  3. Janssen
  4. Amgen
  5. Merck
  6. Abbott
  7. AstraZeneca
  8. Boston Scientific
  9. Bristol Myers Squibb
  10. CryoLife
  11. Chiesi
  12. Daiichi-Sankyo
  13. Eli Lilly
  14. Gilead Sciences
  15. Novartis
  16. Pfizer
  17. Portola
  18. Regeneron
  19. Philips
  20. National Institutes of Health
  21. Sanofi
  22. American Heart Association Strategically Focused Research Network in Vascular Disease [18SFRN3390085, 18SFRN33960262]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.